Back to top

Praxis Advances PRAX-628 Tablet Formulation in Completed Bioavailability Study

Praxis Precision Medicines, Inc. ($PRAX) announced an update on their ongoing clinical study. Praxis PRAX-628 Trial Shows Progress on Next-Gen Epil...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Praxis Precision Medicines, Inc. (PRAX)